Abstract
Cytogenetic analysis of melanoma and nonmelanoma skin cancers has revealed recurrent aberrations, the frequency of which is reflective of malignant potential. Highly aberrant karyotypes are seen in melanoma, squamous cell carcinoma, solar keratosis and Merkel cell carcinoma with more stable karyotypes seen in basal cell carcinoma, keratoacanthoma, Bowen’s disease, dermatofibrosarcomaprotuberans and cutaneous lymphomas. Some aberrations were common amongst a number of skin cancer types including rearrangements and numerical abnormalities of chromosome 1, −3p, +3q, partial or entire trisomy 6, trisomy 7, +8q, −9p, +9q, partial or entire loss of chromosome 10, −17p, + 17q and partial or entire gain of chromosome 20. Combination of cytogenetic analysis with other molecular genetic techniques has enabled the identification of not only aberrant chromosomal regions, but also the genes that contribute to a malignant phenotype. This review provides a comprehensive summary of the pertinent cytogenetic aberrations associated with a variety of melanoma and nonmelanoma skin cancers.
Keywords
- Skin Cancer
- Basal Cell Carcinoma
- Comparative Genomic Hybridization
- Cytogenetic Analysis
- Merkel Cell Carcinoma
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Albert MR, Weinstock MA. Keratinocyte carcinoma. CA Cancer J Clin 2003; 53(5):292–302
Weinstock MA. Epidemiology of nonmelanoma skin cancer: clinical issues, definitions and classification. J Invest Dermatol 1994; 102(6):4S–5S
Gloster HM, Jr. Brodland DG. The epidemiology of skin cancer. Dermatol Surg 1996; 22(3):217–226
Hoglund M, Gisselsson D, Hansen GB et al. Dissecting karyotypic patterns in malignant melanomas: temporal clustering of losses and gains in melanoma karyotypic evolution. Int J Cancer 2004; 108(1):57–65
Sarasin A. The molecular pathways of ultraviolet-induced carcinogenesis. Mutat Res 1999; 428(1–2):5–10
Matsumura Y, Ananthaswamy HN. Toxic effects of ultraviolet radiation on the skin. Toxicol Appl Pharmacol 2004; 195(3):298–308
Emri G, Wenczl E, Van Erp P et al. Low doses of UVB or UVA induce chromosomal aberrations in cultured human skin cells. J Invest Dermatol 2000; 115(3):435–440
Jin Y, Martins C, Jin C et al. Nonrandom karyotypic features in squamous cell carcinomas of the skin. Genes Chromosomes Cancer 1999; 26(4):295–303
Kops GJ, Weaver BA, Cleveland DW. On the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer 2005; 5(10):773–785
Duesberg P, Rasnick D. Aneuploidy, the somatic mutation that makes cancer a species of its own. Cell Motil Cytoskeleton 2000; 47(2):81–107
Klapperstuck T, Wohlrab W. DNA image cytometry on sections as compared with image cytometry on smears and flow cytometry in melanoma. Cytometry 1996; 25(1):82–89
Rapi S, Caldini A, Fanelli A et al. Flow cytometric measurement of DNA content in human solid tumors: a comparison with cytogenetics. Cytometry 1996; 26(3):192–197
Robinson JK, Rademaker AW, Goolsby C et al. DNA ploidy in nonmelanoma skin cancer. Cancer 1996; 77(2):284–291
Williams NN, Daly JM. Flow cytometry and prognostic implications in patients with solid tumors. Surg Gynecol Obstet 1990; 171(3):257–266
Chen Z, Sandberg AA. Molecular cytogenetic aspects of hematological malignancies: clinical implications. Am J Med Genet 2002; 115(3):130–141
Mertens F, Heim S, Mandahl N et al. Cytogenetic analysis of 33 basal cell carcinomas. Cancer Res 1991; 51(3):954–957
Lotem M, Yehuda-Gafni O, Butnaryu E et al. Cytogenetic analysis of melanoma cell lines: subclone selection in long-term melanoma cell cultures. Cancer Genet Cytogenet 2003; 142(2):87–91
James L, Varley J. Advances in cytogenetic analysis of solid tumours. Chromosome Res 1996; 4(7):479–485
Kallioniemi OP, Kallioniemi A, Piper J et al. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 1994; 10(4):231–243
Kallioniemi A, Visakorpi T, Karhu R et al. Gene Copy Number Analysis by Fluorescence in Situ Hybridization and Comparative Genomic Hybridization. Methods 1996; 9(1):113–121
Thompson CT, Gray JW. Cytogenetic profiling using fluorescence in situ hybridization (FISH) and comparative genomic hybridization (CGH). J Cell Biochem Suppl 1993; 17G:139–143
Varella-Garcia M. Molecular cytogenetics in solid tumors: laboratorial tool for diagnosis, prognosis and therapy. Oncologist 2003; 8(1):45–58
Happle R. Loss of heterozygosity in human skin. J Am Acad Dermatol 1999; 41(2 Pt 1):143–164
Forozan F, Mahlamaki EH, Monni O et al. Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data. Cancer Res 2000; 60(16):4519–4525
Okamoto I, Pirker C, Bilban M et al. Seven novel and stable translocations associated with oncogenic gene expression in malignant melanoma. Neoplasia 2005; 7(4):303–311
Platzer P, Upender MB, Wilson K et al. Silence of chromosomal amplifications in colon cancer. Cancer Res 2002; 62(4):1134–1138
Chudnovsky Y, Khavari PA, Adams AE. Melanoma genetics and the development of rational therapeutics. J Clin Invest 2005; 115(4):813–824
Pollock PM, Welch J, Hayward NK. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development. Cancer Res 2001; 61(3):1154–1161
Rager EL, Bridgeford EP, Ollila DW. Cutaneous melanoma: update on prevention, screening, diagnosis and treatment. Am Fam Physician 2005; 72(2):269–276
Skin Cancer Foundation. The Stages of Melanoma. http://www.skincancer.Org/content/view/17/3/l/3/. Accessed 2/3/2007, 2007
Clark WH, Jr. From L, Bernardino EA et al. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 1969; 29(3):705–727
Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970; 172(5):902–908
Hussein MR, Wood GS. Molecular aspects of melanocytic dysplastic nevi. J Mol Diagn 2002; 4(2):71–80
von Roenn JH, Kheir SM, Wolter JM et al. Significance of DNA abnormalities in primary malignant melanoma and nevi, a retrospective flow cytometric study. Cancer Res 1986; 46(6):3192–3195
Kheir SM, Bines SD, Vonroenn JH et al. Prognostic significance of DNA aneuploidy in stage I cutaneous melanoma. Ann Surg 1988; 207(4):455–461
Mitelman Database of Chromosome Aberrations in Cancer. In: Mitelman F, Johansson B, Mertens F. eds. 2006. http://cgap.nci.nih.gov/chromosomes/mitelman.
Cowan JM, Francke U. Cytogenetic analysis in melanoma and nevi. Cancer Treat Res 1991; 54:3–16
Marras S, Faa G, Dettori T et al. Chromosomal changes in dysplastic nevi. Cancer Genet Cytogenet 1999; 113(2):177–179
Richmond A, Fine R, Murray D et al. Growth factor and cytogenetic abnormalities in cultured nevi and malignant melanomas. J Invest Dermatol 1986; 86(3):295–302
Bastian BC, Olshen AB, LeBoit PE et al. Classifying melanocytic tumors based on DNA copy number changes. Am J Pathol 2003; 163(5):1765–1770
Balazs M, Adam Z, Treszl A et al. Chromosomal imbalances in primary and metastatic melanomas revealed by comparative genomic hybridization. Cytometry 2001; 46(4):222–232
Barks JH, Thompson FH, Taetle R et al. Increased chromosome 20 copy number detected by fluorescence in situ hybridization (FISH) in malignant melanoma. Genes Chromosomes Cancer 1997; 19(4):278–285
Utikal J, Udart M, Leiter U et al. Additional Cyclin D(1) gene copies associated with chromosome 11 aberrations in cutaneous malignant melanoma. Int J Oncol 2005; 26(3):597–605
Udart M, Utikal J, Krahn GM et al. Chromosome 7 aneusomy. A marker for metastatic melanoma? Expression of the epidermal growth factor receptor gene and chromosome 7 aneusomy in nevi, primary malignant melanomas and metastases. Neoplasia 2001; 3(3):245–254
Treszl A, Adany R, Rakosy Z et al. Extra copies of c-myc are more pronounced in nodular melanomas than in superficial spreading melanomas as revealed by fluorescence in situ hybridisation. Cytometry B Clin Cytom 2004; 60(1):37–46
Matsuta M, Imamura Y, Matsuta M et al. Detection of numerical chromosomal aberrations in malignant melanomas using fluorescence in situ hybridization. J Cutan Pathol 1997; 24(4):201–205
Hussein MR, Sun M, Roggero E et al. Loss of heterozygosity, microsatellite instability and mismatch repair protein alterations in the radial growth phase of cutaneous malignant melanomas. Mol Carcinog 2002; 34(1):35–44
Hussein MR, Roggero E, Tuthill RJ et al. Identification of novel deletion Loci at 1p36 and 9p22-21 in melanocytic dysplastic nevi and cutaneous malignant melanomas. Arch Dermatol 2003; 139(6):816–817
Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1994; 30(5 Pt 1):774–778
Wong CS, Strange RC, Lear JT. Basal cell carcinoma. Bmj 2003; 327(7418):794–798
Bernstein SC, Lim KK, Brodland DG et al. The many faces of squamous cell carcinoma. Dermatol Surg 1996; 22(3):243–254.
Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol 2002; 146(Suppl 61):1–6.
Skidmore RA, Jr. Flowers FP. Nonmelanoma skin cancer. Med Clin North Am 1998; 82(6):1309–1323, vi
Salasche SJ. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol 2000; 42(1 Pt 2):4–7.
Frost C, Williams G, Green A. High incidence and regression rates of solar keratoses in a queensland community. J Invest Dermatol 2000; 115(2):273–277.
Marks R, Rennie G, Selwood TS. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet 1988; 1(8589):795–797.
Evans C, Cockerell CJ. Actinic keratosis: time to call a spade a spade. South Med J 2000; 93(7):734–736.
Ramrakha-Jones VS, Herd RM. Treating Bowen’s disease: a cost-minimization study. Br J Dermatol 2003; 148(6):1167–1172.
Cohen PR. Bowen’s disease: squamous cell carcinoma in situ. Am Fam Physician 1991; 44(4):1325–1329.
Staibano S, Lo Muzio L, Pannone G et al. DNA ploidy and cyclin D1 expression in basal cell carcinoma of the head and neck. Am J Clin Pathol 2001; 115(6):805–813.
Frentz G, Moller U. Clonal heterogeneity in curetted human epidermal cancers and precancers analysed by flow cytometry and compared with histology. Br J Dermatol 1983; 109(2):173–181.
Fortier-Beaulieu M, Laquerriere A, Thomine E et al. DNA flow-cytometric analysis of basal cell carcinomas and its relevance to their morphological differentiation: a retrospective study. Dermatology 1994; 188(2):94–99.
Pilch H, Weiss J, Heubner C et al. Differential diagnosis of keratoacanthomas and squamous cell carcinomas: diagnostic value of DNA image cytometry and p53 expression. J Cutan Pathol 1994; 21(6):507–513.
Biesterfeld S, Pennings K, Grussendorf-Conen EI et al. Aneuploidy in actinic keratosis and Bowen’s disease—increased risk for invasive squamous cell carcinoma? Br J Dermatol 1995; 133(4):557–560.
Kawara S, Takata M, Takehara K. High frequency of DNA aneuploidy detected by DNA flow cytometry in Bowen’s disease. J Dermatol Sci 1999; 21(1):23–26.
Jin Y, Mertens F, Persson B et al. Nonrandom numerical chromosome abnormalities in basal cell carcinomas. Cancer Genet Cytogenet 1998; 103(1):35–42.
Jin Y, Martins C, Salemark L et al. Nonrandom karyotypic features in basal cell carcinomas of the skin. Cancer Genet Cytogenet 2001; 131(2):109–119.
Casalone R, Mazzola D, Righi R et al. Cytogenetic and interphase FISH analyses of 73 basal cell and three squamous cell carcinomas: different findings in direct preparations and short-term cell cultures. Cancer Genet Cytogenet 2000; 118(2):136–143.
Jin Y, Merterns F, Persson B et al. The reciprocal translocation t(9;16)(q22;p13) is a primary chromosome abnormality in basal cell carcinomas. Cancer Res 1997; 57(3):404–406.
Kawasaki-Oyama RS, Andre FS, Caldeira LF et al. Cytogenetic findings in two basal cell carcinomas. Cancer Genet Cytogenet 1994; 73(2):152–156.
Ashton KJ, Weinstein SR, Maguire DJ et al. Molecular cytogenetic analysis of basal cell carcinoma DNA using comparative genomic hybridization. J Invest Dermatol 2001; 117(3):683–686.
Saridaki Z, Koumantaki E, Liloglou T et al. High frequency of loss of heterozygosity on chromosome region 9p21–p22 but lack of p16INK4a/p19ARF mutations in greek patients with basal cell carcinoma of the skin. J Invest Dermatol 2000; 115(4):719–725.
Quinn AG, Sikkink S, Rees JL. Basal cell carcinomas and squamous cell carcinomas of human skin show distinct patterns of chromosome loss. Cancer Res 1994; 54(17):4756–4759.
Shen T, Park WS, Boni R et al. Detection of loss of heterozygosity on chromosome 9q22.3 in microdissected sporadic basal cell carcinoma. Hum Pathol 1999; 30(3):284–287.
Shanley SM, Dawkins H, Wainwright BJ et al. Fine deletion mapping on the long arm of chromosome 9 in sporadic and familial basal cell carcinomas. Hum Mol Genet 1995; 4(1):129–133.
Jin Y, Jin C, Salemark L et al. Clonal chromosome abnormalities in premalignant lesions of the skin. Cancer Genet Cytogenet 2002; 136(1):48–52.
Heim S, Caron M, Jin Y et al. Genetic convergence during serial in vitro passage of a polyclonal squamous cell carcinoma. Cytogenet Cell Genet 1989; 52(3—4):133–135.
Kim DK, Kim JY, Kim HT et al. A specific chromosome aberration in a keratoacanthoma. Cancer Genet Cytogenet 2003; 142(1):70–72.
Mertens F, Heim S, Mandahl N et al. Clonal chromosome aberrations in a keratoacanthoma and a basal cell papilloma. Cancer Genet Cytogenet 1989; 39(2):227–232.
Ashton KJ, Weinstein SR, Maguire DJ et al. Chromosomal aberrations in squamous cell carcinoma and solar keratoses revealed by comparative genomic hybridization. Arch Dermatol 2003; 139(7):876–882.
Clausen OP, Beigi M, Bolund L et al. Keratoacanthomas frequently show chromosomal aberrations as assessed by comparative genomic hybridization. J Invest Dermatol 2002; 119(6):1367–1372.
Clausen OP, Aass HC, Beigi M et al. Are keratoacanthomas variants of squamous cell carcinomas? A comparison of chromosomal aberrations by comparative genomic hybridization. J Invest Dermatol 2006; 126(10):2308–2315.
Rehman I, Takata M, Wu YY et al. Genetic change in actinic keratoses. Oncogene 1996; 12(12):2483–2490.
Lee HJ, Kim JS, Ha SJ et al. p53 gene mutations in Bowen’s disease in Koreans: clustering in exon 5 and multiple mutations. Cancer Lett 2000; 158(1):27–33.
Mortier L, Marchetti P, Delaporte E et al. Progression of actinic keratosis to squamous cell carcinoma of the skin correlates with deletion of the 9p21 region encoding the pl6(INK4a) tumor suppressor. Cancer Lett 2002; 176(2):205–214.
Waring AJ, Takata M, Rehman I et al. Loss of heterozygosity analysis of keratoacanthoma reveals multiple differences from cutaneous squamous cell carcinoma. Br J Cancer 1996; 73(5):649–653.
Van Gele M, Speleman F, Vandesompele J et al. Characteristic pattern of chromosomal gains and losses in Merkel cell carcinoma detected by comparative genomic hybridization. Cancer Res 1998;58(7):1503–1508.
Kaur S, Vauhkonen H, Bohling T et al. Gene copy number changes in dermatofibrosarcoma protuberans-a fine-resolution study using array comparative genomic hybridization. Cytogenet Genome Res 2006; 115(3–4):283–288.
Scarisbrick JJ, Woolford AJ, Russell-Jones R et al. Allelotyping in mycosis fungoides and Sezary syndrome: common regions of allelic loss identified on 9p, 10q and 17p. J Invest Dermatol 2001; 117(3):663–670.
Hoefnagel JJ, Dijkman R, Basso K et al. Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling. Blood 2005; 105(9):3671–3678.
Leonard JH, Leonard P, Kearsley JH. Chromosomes 1, 11 and 13 are frequently involved in karyotypic abnormalities in metastatic Merkel cell carcinoma. Cancer Genet Cytogenet 1993; 67(1):65–70.
Larramendy ML, Koljonen V, Bohling T et al. Recurrent DNA copy number changes revealed by comparative genomic hybridization in primary Merkel cell carcinomas. Mod Pathol 2004; 17(5):561–567.
Van Gele M, Leonard JH, Van Roy N et al. Frequent allelic loss at 10q23 but low incidence of PTEN mutations in Merkel cell carcinoma. Int J Cancer 2001; 92(3):409–413.
Vortmeyer AO, Merino MJ, Boni R et al. Genetic changes associated with primary Merkel cell carcinoma. Am J Clin Pathol 1998; 109(5):565–570.
Kiuru-Kuhlefelt S, El-Rifai W, Fanburg-Smith J et al. Concomitant DNA copy number amplification at 17q and 22q in dermatofibrosarcoma protuberans. Cytogenet Cell Genet 2001; 92(3–4):192–195.
Nishio J, Iwasaki H, Ohjimi Y et al. Overrepresentation of 17q22-qter and 22q13 in dermatofibrosarcoma protuberans but not in dermatofibroma: a comparative genomic hybridization study. Cancer Genet Cytogenet 2002;132(2):102–108.
Mao X, Lillington D, Scarisbrick JJ et al. Molecular cytogenetic analysis of cutaneous T-cell lymphomas: identification of common genetic alterations in Sezary syndrome and mycosis fungoides. Br J Dermatol 2002; 147(3):464–475.
Streubel B, Scheucher B, Valencak J et al. Molecular cytogenetic evidence of t(14;18)(IGH;BCL2) in a substantial proportion of primary cutaneous follicle center lymphomas. Am J Surg Pathol 2006; 30(4):529–536.
Hallermann C, Kaune KM, Gesk S et al. Molecular cytogenetic analysis of chromosomal breakpoints in the IGH, MYC, BCL6 and MALT1 gene loci in primary cutaneous B-cell lymphomas. J Invest Dermatol 2004; 123(1):213–219.
Gimenez S, Costa C, Espinet B et al. Comparative genomic hybridization analysis of cutaneous large B-cell lymphomas. Exp Dermatol 2005; 14(12):883–890.
Santos GC, Zielenska M, Prasad M et al. Chromosome 6p amplification and cancer progression. J Clin Pathol 2007; 60(1):1–7.
Scarisbrick JJ, Woolford AJ, Russell-Jones R et al. Loss of heterozygosity on 10q and microsatellite instability in advanced stages of primary cutaneous T-cell lymphoma and possible association with homozygous deletion of PTEN. Blood 2000; 95(9):2937–2942.
Miyaki M, Kuroki T. Role of Smad4 (DPC4) inactivation in human cancer. Biochem Biophys Res Commun 2003; 306(4):799–804.
Tian F, DaCosta Byfield S, Parks WT et al. Reduction in Smad2/3 signaling enhances tumorigenesis but suppresses metastasis of breast cancer cell lines. Cancer Res 2003; 63(23):8284–8292.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Landes Bioscience and Springer Science+Business Media
About this chapter
Cite this chapter
Carless, M.A., Griffiths, L.R. (2008). Cytogenetics of Melanoma and Nonmelanoma Skin Cancer. In: Reichrath, J. (eds) Sunlight, Vitamin D and Skin Cancer. Advances in Experimental Medicine and Biology, vol 624. Springer, New York, NY. https://doi.org/10.1007/978-0-387-77574-6_18
Download citation
DOI: https://doi.org/10.1007/978-0-387-77574-6_18
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-77573-9
Online ISBN: 978-0-387-77574-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)